Linked Life Data

15685240

Source:http://linkedlifedata.com/resource/pubmed/id/15685240

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-2-9
pubmed:abstractText
The inhibitor of apoptosis protein, XIAP, is frequently overexpressed in chemoresistant human tumours. An antisense oligonucleotide (AEG 35156/GEM 640) that targets XIAP has recently entered phase I trials in the UK. Method validation data are presented on three pharmacodynamic assays that will be utilised during this trial. Quantitative RT-PCR was based on a Taqman assay and was confirmed to be specific for XIAP. Assay linearity extended over four orders of magnitude. MDA-MB-231/U6-E1 cells and clone X-G4 stably expressing an RNAi vector against XIAP were chosen as high and low XIAP expression quality controls (QCs). Within-day and between-day coefficients of variation (CVs) in precision for cycle threshold (CT) and delta CT values (employing GAPDH and beta 2 microglobulin as housekeepers) were always less than 10%. A Western blotting technique was validated using a GST-XIAP fusion protein as a standard and HeLa cells and SF268 (human glioblastoma) cells as high and low XIAP expression QCs. Specificity of the final choice of antibody for XIAP was evaluated by analysing a panel of cell lines including clone X-G4. The assay was linear over a 29-fold range of protein concentration and between-day precision was 29% for the low QC and 23% for the high QC when normalised to GAPDH. XIAP protein was also shown to be stable at -80 degrees C for at least 60 days. M30-Apoptosense plasma Elisa detects a caspase-cleaved fragment of cytokeratin 18 (CK18), believed to be a surrogate marker for tumour cell apoptosis. Generation of an independent QC was achieved through the treatment of X-G4 cells with staurosporine and collection of media. Measurements on assay precision and kit-to-kit QC were always less than 10%. The M30 antigen (CK18-Asp396) was stable for 3 months at -80 degrees C, while at 37 degrees C it had a half-life of 80-100 h in healthy volunteer plasma. Results from the phase I trial are eagerly awaited.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-10398123, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-10815900, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-10953315, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11048727, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11087668, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11095261, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11100055, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11162351, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11303967, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11313486, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11433370, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11445667, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11489828, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11683255, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11852247, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-11877747, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12027563, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12114409, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12363038, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12381371, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12384799, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12455050, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12651202, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12678873, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12733138, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12766486, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12853650, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12855663, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12855666, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12866371, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-12874265, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-14532997, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-14581366, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-14634619, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-14749118, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-14749124, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-15173080, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-15297970, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-15328523, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-15378029, http://linkedlifedata.com/resource/pubmed/commentcorrection/15685240-9916987
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
532-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
More...